Sun J, Halfvarson J, Bergman D, et al. Statin use and risk of colorectal cancer in patients with inflammatory bowel disease. EClinicalMedicine. 2023;63:102182.

Article  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.

Article  PubMed  Google Scholar 

Waldum H, Fossmark R. Inflammation and digestive cancer. Int J Mol Sci. 2023;24(17):13503.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eaden J. Review article: colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(4):24–30.

Article  PubMed  Google Scholar 

Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Porter RJ, Arends MJ, Churchhouse A, et al. Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines. J Crohn’s Colitis. 2021. https://doi.org/10.1093/ecco-jcc/jjab102.

Article  Google Scholar 

Soomro S, Venkateswaran S, Vanarsa K, et al. Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen. Nat Commun. 2021;12(1):1–11.

Article  Google Scholar 

Gasparetto M, Payne F, Nayak K, et al. Transcription and DNA methylation patterns of blood-derived CD8+ T cells are associated with age and inflammatory bowel disease but do not predict prognosis. Gastroenterology. 2021;160(1):232-44.e7.

Article  CAS  PubMed  Google Scholar 

Fazio A, Bordoni D, Kuiper JW, et al. DNA methyltransferase 3A controls intestinal epithelial barrier function and regeneration in the colon. Nat Commun. 2022;13(1):1–19.

Article  Google Scholar 

Hirsch D, Hardt J, Sauer C, et al. Molecular characterization of ulcerative colitis-associated colorectal carcinomas. Mod Pathol. 2021;34(6):1153–66.

Article  CAS  PubMed  Google Scholar 

Rajamäki K, Taira A, Katainen R, et al. Genetic and epigenetic characteristics of inflammatory bowel disease associated colorectal cancer. Gastroenterology. 2021. https://doi.org/10.1053/j.gastro.2021.04.042.

Article  PubMed  Google Scholar 

Li J, Ma X, Chakravarti D, et al. Genetic and biological hallmarks of colorectal cancer. Genes Dev. 2021;35(11–12):787–820.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsumoto K, Urabe Y, Oka S, et al. Genomic landscape of early-stage colorectal neoplasia developing from the ulcerative colitis mucosa in the Japanese population. Inflamm Bowel Dis. 2021;27(5):686–96.

Article  PubMed  Google Scholar 

Huang D, Sun W, Zhou Y, et al. Mutations of key driver genes in colorectal cancer progression and metastasis. Cancer Metastasis Rev. 2018;37(1):173–87.

Article  CAS  PubMed  Google Scholar 

Brentnall TA, Crispin DA, Rabinovitch PS, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology. 1994;107(2):369.

Article  CAS  PubMed  Google Scholar 

Aust DE, Terdiman JP, Willenbucher RF, et al. The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer. 2002;94(5):1421–7.

Article  CAS  PubMed  Google Scholar 

Wei M, Ma Y, Shen L, et al. NDRG2 regulates adherens junction integrity to restrict colitis and tumourigenesis. EBioMedicine. 2020;61:103068.

Article  PubMed  PubMed Central  Google Scholar 

Kumar A, Priyamvada S, Ge Y, et al. A novel role of SLC26A3 in the maintenance of intestinal epithelial barrier integrity. Gastroenterology. 2021;160(4):1240-55.e3.

Article  CAS  PubMed  Google Scholar 

Grosheva I, Zheng D, Levy M, et al. High-throughput screen identifies host and microbiota regulators of intestinal barrier function. Gastroenterology. 2020;159(5):1807–23.

Article  CAS  PubMed  Google Scholar 

Spalinger MR, Sayoc-Becerra A, Santos AN, et al. PTPN2 regulates interactions between macrophages and intestinal epithelial cells to promote intestinal barrier function. Gastroenterology. 2020;159(5):1763-77.e14.

Article  CAS  PubMed  Google Scholar 

Sahoo D, Swanson L, Sayed IM, et al. Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease. Nat Commun. 2021;12(1):1–14.

Article  Google Scholar 

Grivennikov S, Karin E, Terzic J, et al. IL-6 and STAT3 are required for survival of intestinal epithelial cells and development of colitis associated cancer. Cancer Cell. 2009;15(2):103–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meir M, Burkard N, Ungewiß H, et al. Neurotrophic factor GDNF regulates intestinal barrier function in inflammatory bowel disease. J Clin Investig. 2019;129(7):2824–40.

Article  PubMed  PubMed Central  Google Scholar 

Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392.

Article  CAS  PubMed  Google Scholar 

Hidalgo García L, Molina Tijeras JA, Huertas Peña FJ, et al. Intestinal mesenchymal cells regulate immune responses and promote epithelial regeneration in vitro and in dextran sulfate sodium-induced experimental colitis in mice. Acta Physiol. 2021. https://doi.org/10.1111/apha.13699.

Article  Google Scholar 

Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539.

Article  CAS  PubMed  Google Scholar 

Zhu W, Miyata N, Winter MG, et al. Editing of the gut microbiota reduces carcinogenesis in mouse models of colitis-associated colorectal cancer. J Exp Med. 2019;216(10):2378–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cohen LJ, Cho JH, Gevers D, et al. Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases. Gastroenterology. 2019;156(8):2174–89.

Article  PubMed  Google Scholar 

López-Posadas R, Neurath MF, Atreya I. Molecular pathways driving disease-specific alterations of intestinal epithelial cells. Cell Mol Life Sci. 2017;74(5):803–26.

Article  PubMed  Google Scholar 

Hu S, Venema WTU, Westra H-J, et al. Inflammation status modulates the effect of host genetic variation on intestinal gene expression in inflammatory bowel disease. Nat Commun. 2021;12(1):1–10.

Google Scholar 

Xiao L, Li X-X, Chung HK, et al. RNA-binding protein HuR regulates Paneth cell function by altering membrane localization of TLR2 via post-transcriptional control of CNPY3. Gastroenterology. 2019;157(3):731–43.

Article  CAS  PubMed  Google Scholar 

Yu S, Balasubramanian I, Laubitz D, et al. Paneth cell-derived lysozyme defines the composition of mucolytic microbiota and the inflammatory tone of the intestine. Immunity. 2020;53(2):398-416.e8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2015;14(1):20–32.

Article  PubMed  PubMed Central  Google Scholar 

Banerjee A, Herring CA, Chen B, et al. Succinate produced by intestinal microbes promotes specification of tuft cells to suppress ileal inflammation. Gastroenterology. 2020;159(6):2101-155.e5.

Article  CAS  PubMed  Google Scholar 

Balasubramanian I, Gao N. From sensing to shaping microbiota: insights into the role of NOD2 in intestinal homeostasis and progression of Crohn’s disease. Am J Physiol Gastrointest Liver Physiol. 2017;313(1):G7–13.

Article  PubMed  PubMed Central  Google Scholar 

Landi MT, Bishop DT, MacGregor S, et al. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nat Genet. 2020;52(5):494–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Z-Y, Zheng M, Li Y-M, et al. RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression. Theranostics. 2019;9(12):3659.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou M, He J, Shi Y, et al. ABIN3 negatively regulates necroptosis-induced intestinal inflammation through recruiting A20 and restricting the ubiquitination of RIPK3 in inflammatory bowel disease. J Crohns Colitis. 2021;15(1):99–114.

Article  PubMed  Google S